These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 8431918)
1. t(5;12)(q31;p12). A clinical entity with features of both myeloid leukemia and chronic myelomonocytic leukemia. Wessels JW; Fibbe WE; van der Keur D; Landegent JE; van der Plas DC; den Ottolander GJ; Roozendaal KJ; Beverstock GC Cancer Genet Cytogenet; 1993 Jan; 65(1):7-11. PubMed ID: 8431918 [TBL] [Abstract][Full Text] [Related]
2. A t(3;5) in blastic phase of a Philadelphia chromosome-negative chronic myeloid leukemia. De Braekeleer M; Vekemans M Cancer Genet Cytogenet; 1989 Feb; 37(2):163-8. PubMed ID: 2702617 [TBL] [Abstract][Full Text] [Related]
3. Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia. Li B; Gale RP; Xiao Z J Hematol Oncol; 2014 Dec; 7():93. PubMed ID: 25498990 [TBL] [Abstract][Full Text] [Related]
4. Translocation of BCR to chromosome 9 in a Philadelphia-negative chronic myeloid leukemia. Brunel V; Sainty D; Costello R; Mozziconacci MJ; Simonetti J; Arnoulet C; Coignet L; Bouabdallah R; Gastaut JA; Gabert J Cancer Genet Cytogenet; 1995 Nov; 85(1):82-4. PubMed ID: 8536245 [TBL] [Abstract][Full Text] [Related]
5. Molecular and cytogenetic studies of a patient with Philadelphia-negative, BCR-positive chronic myeloid leukemia and t(12;12)(q13;p12). Zaccaria A; Testoni N; Tassinari A; Celso B; Emanuel BS; Budarf M; Saglio G; Guerrasio A; Barletta C; Peschle C Genes Chromosomes Cancer; 1990 Mar; 1(4):284-8. PubMed ID: 2278960 [TBL] [Abstract][Full Text] [Related]
6. Identification of a rare e6a2 BCR-ABL fusion gene during the disease progression of chronic myelomonocytic leukemia: a case report. Hayette S; Tigaud I; Thomas X; French M; Perrin MC; Nicolini F; Michallet M; Magaud JP Leukemia; 2004 Oct; 18(10):1735-6. PubMed ID: 15356652 [No Abstract] [Full Text] [Related]
7. Translocation t(9;9)(p13;q34) in Philadelphia-negative chronic myeloid leukemia with breakpoint cluster region rearrangement. Sessarego M; Mareni C; Vimercati R; Defferrari R; Origone P; Damasio E; Ajmar F Cancer Genet Cytogenet; 1989 Nov; 43(1):51-6. PubMed ID: 2790772 [TBL] [Abstract][Full Text] [Related]
8. Translocation t(5;12)(q31-q33;p12-p13): a non-random translocation associated with a myeloid disorder with eosinophilia. Baranger L; Szapiro N; Gardais J; Hillion J; Derre J; Francois S; Blanchet O; Boasson M; Berger R Br J Haematol; 1994 Oct; 88(2):343-7. PubMed ID: 7803280 [TBL] [Abstract][Full Text] [Related]
9. Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML. van der Plas DC; Grosveld G; Hagemeijer A Cancer Genet Cytogenet; 1991 Apr; 52(2):143-56. PubMed ID: 2021916 [TBL] [Abstract][Full Text] [Related]
10. Two balanced and novel chromosomal translocations in myeloid malignancies. characterization by multiplex fluorescence in situ hybridization. Wan TS; Ma SK; Yip SF; Yeung YM; Chan LC Cancer Genet Cytogenet; 2002 Nov; 139(1):52-6. PubMed ID: 12547159 [TBL] [Abstract][Full Text] [Related]
11. A Ph-negative chronic myeloid leukemia with a complex BCR/ABL rearrangement and a t(6;9)(p21;q34.1). Todorić-Zivanović B; Marisavljević D; Surace C; Cemerikić V; Marković O; Krtolica K; Tatomirović Z; Cikota B; Magić Z; Rocchi M Cancer Genet Cytogenet; 2006 Apr; 166(2):180-5. PubMed ID: 16631477 [TBL] [Abstract][Full Text] [Related]
12. Late appearance of t(5;12)(q31;p12) in acute myeloid leukemia associated with eosinophilia. Yahata N; Ohyashiki K; Ohyashiki JH; Kimura Y; Miyazawa K; Kodama A; Fukutake K; Toyama K Cancer Genet Cytogenet; 1998 Dec; 107(2):147-50. PubMed ID: 9844611 [TBL] [Abstract][Full Text] [Related]
13. ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia. Ito Y; Shimamoto T; Kuriyama Y; Nakajima A; Sumi M; Watanabe Y; Beppu H; Ohtsubo K; Ohyashiki K Leukemia; 2002 May; 16(5):951-2. PubMed ID: 11986960 [No Abstract] [Full Text] [Related]
14. Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia. Kantarjian HM; Shtalrid M; Kurzrock R; Blick M; Dalton WT; LeMaistre A; Stass SA; McCredie KB; Gutterman J; Freireich EJ Am J Med; 1988 Nov; 85(5):639-44. PubMed ID: 3189367 [TBL] [Abstract][Full Text] [Related]
15. Presence of t(1;14)(p13;p11.2) in Philadelphia chromosome-negative cells in a patient with chronic myeloid leukemia. Medeiros BC; Markovic V; Kamel-Reid S; Lipton JH Cancer Genet Cytogenet; 2007 Feb; 173(1):83-4. PubMed ID: 17284377 [No Abstract] [Full Text] [Related]
19. Cytogenetic and molecular studies of the Philadelphia translocation in myelodysplastic syndromes. Report of two cases and review of the literature. Verhoef G; Meeus P; Stul M; Mecucci C; Cassiman JJ; Van Den Berghe H; Boogaerts M Cancer Genet Cytogenet; 1992 Apr; 59(2):161-6. PubMed ID: 1581881 [TBL] [Abstract][Full Text] [Related]